Royal Bank of Canada’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-44,508
Closed -$1.59M 6709
2014
Q4
$1.59M Buy
44,508
+22,422
+102% +$669K ﹤0.01% 2516
2014
Q3
$573K Sell
22,086
-14,866
-40% -$427K ﹤0.01% 3337
2014
Q2
$1.22M Buy
36,952
+33,695
+1,035% +$973K ﹤0.01% 2665
2014
Q1
$98K Buy
3,257
+405
+14% +$14K ﹤0.01% 4556
2013
Q4
$86K Sell
2,852
-21,638
-88% -$596K ﹤0.01% 4661
2013
Q3
$779K Sell
24,490
-7,110
-23% -$163K ﹤0.01% 3003
2013
Q2
$477K Buy
+31,600
New +$438K ﹤0.01% 3202

Other funds holding NPSP

Royal Bank of Canada's NPSP Position: Q1 2015 in Review

Royal Bank of Canada sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 44,508 shares — an estimated $1.59M sold.

Royal Bank of Canada first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $1.59M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • Royal Bank of Canada reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Royal Bank of Canada sold 44,508 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.59M.
  • Royal Bank of Canada first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Royal Bank of Canada's NPS PHARMACEUTICALS INC position peaked at $1.59M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Royal Bank of Canada's 13F filing for Q1 2015, filed 15 May 2015.